GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Drug Metabolism And Disposition

• Publication date

  2005-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/DMD.104.002527PMID 15843492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vitro inhibitory effects of non‐steroidal antiinflammatory drugs on UDP‐glucuronosyltransferase 1A1‐catalysed estradiol 3β‐glucuronidation in human liver microsomes

  2005cited by this paper
• Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP‐glucuronosyltransferase UGT1A4

  2004cited by this paper
• Gastrointestinally Distributed UDP-glucuronosyltransferase 1A10, Which Metabolizes Estrogens and Nonsteroidal Anti-inflammatory Drugs, Depends upon Phosphorylation*

  2004influential reference
• Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.

  2004cited by this paper
• Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms.

  2004cited by this paper
• Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity

  2004cited by this paper
• Functional polymorphisms of UDP-glucuronosyltransferases 1A1, 1A6 and 1A8 are not involved in chronic pancreatitis.

  2004cited by this paper
• A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity.

  2004cited by this paper
• Acyl glucuronide reactivity in perspective: biological consequences.

  2003cited by this paper
• N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases.

  2003influential reference
• Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.

  2003cited by this paper
• Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications

  2003cited by this paper
• Novel Functional Polymorphisms in the UGT1A7 and UGT1A9 Glucuronidating Enzymes in Caucasian and African-American Subjects and Their Impact on the Metabolism of 7-Ethyl-10-hydroxycamptothecin and Flavopiridol Anticancer Drugs

  2003cited by this paper
• Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7.

  2003cited by this paper
• Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.

  2002cited by this paper
• Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).

  2002cited by this paper
• Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.

  2002cited by this paper
• Biosynthesis of drug glucuronides for use as authentic standards.

  2002cited by this paper
• Imipramine N-glucuronidation in human liver microsomes: biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms.

  2002cited by this paper
• Standardization of a LC/MS/MS Method for the Determination of Acyl Glucuronides and Their Isomers

  2002cited by this paper
• Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9.

  2002cited by this paper
• Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3.

  2002cited by this paper
• Characterization of nicotine and cotinine N-glucuronidations in human liver microsomes.

  2002cited by this paper
• Genetic polymorphisms of UDP-glucuronosyltransferase in Asians: UGT1A1*28 is a common allele in Indians.

  2002cited by this paper
• Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.

  2001cited by this paper
• Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin

  2001cited by this paper
• Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7.

  2000influential reference
• Nonsteroidal anti-inflammatory drugs and cancer prevention.

  2000cited by this paper
• Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y).

  2000cited by this paper
• The specificity of glucuronidation of entacapone and tolcapone by recombinant human UDP-glucuronosyltransferases.

  2000influential reference
• Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

  2000cited by this paper
• UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations.

  1999cited by this paper
• Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene.

  1999cited by this paper
• Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.

  1999cited by this paper
• Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3.

  1998influential reference
• Characterization of two UDP glucuronosyltransferases that are predominantly expressed in human colon.

  1998cited by this paper
• Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.

  1998influential reference
• Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.

  1997cited by this paper
• The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.

  1997cited by this paper
• A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes.

  1997influential reference
• Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications.

  1997cited by this paper
• Human UGT2B7 catalyzes morphine glucuronidation.

  1997cited by this paper
• Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

  1997cited by this paper
• Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man.

  1994cited by this paper
• Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs.

  1993cited by this paper
• Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4.

  1993cited by this paper
• Procedures to Characterize In Vivo and In Vitro Enantioselective Glucuronidation Properly: Studies with Benoxaprofen Glucuronides

  1989cited by this paper
• Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes.

  1988cited by this paper
• from Human Liver

  1976cited by this paper

• Фармацевтична опіка за больового синдрому: оцінка обізнаності фармацевтів щодо застосування нестероїдних протизапальних препаратів і профілактики їхніх ускладнень

  2026cites this paper
• Model‐Informed Drug Development Supports Full Approval of Ibuprofen Injection in Chinese Pediatric Patients With Fever or Pain

  2025cites this paper
• Microfluidic device successfully replaces traditional models of pregnancy associated drug pharmacokinetic studies

  2025cites this paper
• Effect of Prolonged-acting Insulin on Intestinal and Hepatic Metabolism of 4-nitrophenol in STZ-Induced Experimental Diabetes

  2025cites this paper
• Metabolite Measurement in Index Substrate Drug Interaction Studies: A Review of the Literature and Recent New Drug Application Reviews

  2024cites this paper
• Clotrimazole Identified as a Selective UGT2B4 Inhibitor Using Canagliflozin-2′-O-Glucuronide Formation as a Selective UGT2B4 Probe Reaction

  2024cites this paper
• Comparative in vitro hepatic clearances of commonly used antidepressants, antipsychotics, and anti-inflammatory agents in rainbow trout liver S9 fractions.

  2024cites this paper
• Resolvins D5 and D1 undergo Phase II Metabolism by Uridine 5'-diphospho-glucuronosyltransferases.

  2024cites this paper
• Bioequivalence risk assessment of oral formulations containing racemic ibuprofen through a chiral physiologically based pharmacokinetic model of ibuprofen enantiomers.

  2024cites this paper
• New bacterial strains for ibuprofen biodegradation: Drug removal, transformation, and potential catabolic genes

  2024cites this paper
• Herbal Remedies and Modern Pharmacology: A Comprehensive Approach to Inflammation Management

  2024cites this paper
• Ketoprofen in horses: Metabolism, pharmacokinetics, and effects on inflammatory biomarkers.

  2023cites this paper
• Zeolite integrated carbon paste sensors for sensitive and selective differential pulse voltammetric determination of carprofen

  2023cites this paper
• Comparison of intravenous ibuprofen pharmacokinetics between Caucasian and Chinese populations using physiologically based pharmacokinetics modeling and simulation.

  2023cites this paper
• Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.

  2023cites this paper
• Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

  2022cites this paper
• Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life

  2022cites this paper
• Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review

  2022cites this paper
• Stereoselective Covalent Adduct Formation of Acyl Glucuronide Metabolite of Nonsteroidal Anti-Inflammatory Drugs with UDP-Glucuronosyltransferase

  2022influential citation
• Relationship between the risk of idiosyncratic drug toxicity and formation and degradation profiles of acyl-glucuronide metabolites of nonsteroidal anti-inflammatory drugs in rat liver microsomes.

  2022cites this paper
• Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy

  2021cites this paper
• Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity

  2021cites this paper
• Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase.

  2021cites this paper
• Phytochemical and Over-The-Counter Drug Interactions: Involvement of Phase I and II Drug-Metabolizing Enzymes and Phase III Transporters

  2021cites this paper
• In vitro modulatory effects of ginsenoside compound K, 20(S)-protopanaxadiol and 20(S)-protopanaxatriol on uridine 5′-diphospho-glucuronosyltransferase activity and expression

  2021cites this paper
• The Functionality of UDP-Glucuronosyltransferase Genetic Variants and their Association with Drug Responses and Human Diseases

  2021cites this paper
• Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective

  2020cites this paper
• Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs

  2020cites this paper
• Inhibition of 20-hydroxyeicosatetraenoic acid (20-HETE) glucuronidation by non-steroidal anti-inflammatory drugs in human liver microsomes and recombinant UDP-glucuronosyltransferase enzymes.

  2020cites this paper
• Population Pharmacokinetics of Sulindac and Genetic Polymorphisms of FMO3 and AOX1 in Women with Preterm Labor

  2020cites this paper
• Inhibition of Human UDP-Glucuronosyltransferase Enzyme by Belinostat: Implications for Drug-Drug Interactions.

  2020cites this paper
• Do postpartum nonsteroidal antiinflammatory drugs (NSAIDs) affect neonatal hyperbilirubinaemia?

  2020cites this paper
• Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen

  2020cites this paper
• Identification of sulfonyl‐loxoprofen as novel phase 2 conjugate in rat

  2019cites this paper
• Regioselectivity significantly impacts microsomal glucuronidation efficiency of R/S-6, 7-, and 8-hydroxywarfarin

  2019cites this paper
• Determination of low intrinsic clearance in vitro: the benefit of a novel internal standard in human hepatocyte incubations

  2019cites this paper
• Relative Expression of Mouse Udp-Glucuronosyl Transferase 2b1 Gene in The Livers, Kidneys, And Hearts: The Influence of Nonsteroidal Anti-Inflammatory Drug Treatment.

  2019cites this paper
• Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population

  2019cites this paper
• Investigation of intestinal elimination and biliary excretion of ibuprofen in control and hyperglycemic rats.

  2019influential citation
• Anti-inflammatory, anti-nociceptive and sedative-hypnotic activities of lucidone D extracted from Ganoderma lucidum.

  2019cites this paper
• Sigmoidal kinetics define porcine intestinal segregation of electrogenic monosaccharide transport systems as having multiple transporter population involvement

  2019cites this paper
• Characterizing Intestinal Glucose Absorption in Mammalian Pig and Aquatic Species Tilapia and Trout

  2019cites this paper
• Association between the UGT1A1*28 allele and hyperbilirubinemia in HIV-positive patients receiving atazanavir: a meta-analysis

  2019cites this paper
• Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22)

  2019influential citation
• Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design.

  2019cites this paper
• The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.

  2019cites this paper
• Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone

  2019cites this paper
• Intestinal electrogenic sodium-dependent glucose absorption in tilapia and trout reveal species differences in SLC5A-associated kinetic segmental segregation.

  2019cites this paper
• Inhibition of UGT1A1 by natural and synthetic flavonoids.

  2019cites this paper
• Chemo-Enzymatic Synthesis, Structural and Stereochemical Characterization, and Intrinsic Degradation Kinetics of Diastereomers of 1-β-O-Acyl Glucuronides Derived from Racemic 2-{4-[(2-Methylprop-2-en-1-yl)amino]phenyl}propanoic Acid

  2018cites this paper
• Participation of ATP‐sensitive K+ channels and μ‐opioid receptors in the antinociceptive synergism of the paracetamol–tapentadol co‐administration in the formalin‐induced pain assay in mice

  2018cites this paper
• Effects of body condition score (BCS) on steroid‐ and eicosanoid‐metabolizing enzyme activity in various mare tissues during winter anoestrus

  2018cites this paper
• In vitro inhibition of human UGT isoforms by ritonavir and cobicistat

  2018cites this paper
• Correlation between glucuronidation and covalent adducts formation with proteins of nonsteroidal anti‐inflammatory drugs

  2018cites this paper
• Chemical Probes for Human UDP‐Glucuronosyltransferases: A Comprehensive Review

  2018cites this paper
• Exploring the Metabolism of Loxoprofen in Liver Microsomes: The Role of Cytochrome P450 and UDP-Glucuronosyltransferase in Its Biotransformation

  2018cites this paper
• Linking Aromatic Hydroxy Metabolic Functionalization of Drug Molecules to Structure and Pharmacologic Activity

  2018cites this paper
• Toxicological potential of acyl glucuronides and its assessment.

  2017cites this paper
• Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics

  2017cites this paper
• Stereoselective hepatic disposition of ibuprofen in the perfused liver of rat with adjuvant-induced arthritis

  2017cites this paper
• Recent advances in the prediction of non‐CYP450‐mediated drug metabolism

  2017cites this paper
• Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment

  2017cites this paper
• In Vitro Comparative Study of the Inhibitory Effects of Mangiferin and Its Aglycone Norathyriol towards UDP-Glucuronosyl Transferase (UGT) Isoforms

  2017cites this paper
• Characterization of drug disposition in humans using novel in vitro methodologies based on the Extended Clearance Model

  2017cites this paper
• Predicting substrate selectivity between UGT1A9 and UGT1A10 using molecular modelling and molecular dynamics approach

  2016cites this paper
• Running title: Glucuronidation and drug-induced toxicity in humanized UGT1 mice

  2016cites this paper
• Simultaneous quantification of propranolol and sulfamethoxazole and major human metabolite conjugates 4-hydroxy-propranolol sulfate and sulfamethoxazole-β-glucuronide in municipal wastewater-A framework for multiple classes of drugs and conjugates.

  2016cites this paper
• Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

  2015cites this paper
• Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy

  2015cites this paper
• PharmGKB summary: ibuprofen pathways

  2015cites this paper
• Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.

  2015cites this paper
• Phase II Metabolism in Human Skin: Skin Explants Show Full Coverage for Glucuronidation, Sulfation, N-Acetylation, Catechol Methylation, and Glutathione Conjugation

  2015cites this paper
• Corrigendum: Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions

  2015cites this paper
• Inhibition screening method of microsomal UGTs using the cocktail approach.

  2015cites this paper
• Low β2-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism

  2015cites this paper
• Targeted Screen for Human UDP-Glucuronosyltransferases Inhibitors and the Evaluation of Potential Drug-Drug Interactions with Zafirlukast

  2015cites this paper
• Drug metabolism and hypersensitivity reactions to drugs

  2015cites this paper
• Significantly Different Covalent Binding of Oxidative Metabolites, Acyl Glucuronides, and S-Acyl CoA Conjugates Formed from Xenobiotic Carboxylic Acids in Human Liver Microsomes.

  2015cites this paper
• A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development.

  2015cites this paper
• Synthesis and in vitro bioactivity evaluation of new glucose and xylitol ester derivatives of 5-aminosalicylic acid

  2015cites this paper
• Current trends in environmental analysis of human metabolite conjugates of pharmaceuticals

  2015cites this paper
• Establishment of pharmacophore and VolSurf models to predict the substrates of UDP-glucuronosyltransferase1A3

  2015cites this paper
• The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: Haplotype associations and gene–environment interactions

  2014influential citation
• The Pharmacokinetics and Clinical Efficacy of Oral Carprofen in the Laboratory Mouse

  2014cites this paper
• Strategies for the modulation of phase II metabolism in a series of PKCε inhibitors.

  2014cites this paper
• Glucuronidation of Drugs and Drug-Induced Toxicity in Humanized UDP-Glucuronosyltransferase 1 Mice

  2014cites this paper
• Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry

  2014cites this paper
• Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review.

  2014cites this paper
• Transcriptional regulation of human UDP-glucuronosyltransferase genes

  2014cites this paper
• Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review.

  2014cites this paper
• An Orphan Esterase ABHD10 Modulates Probenecid Acyl Glucuronidation in Human Liver

  2014cites this paper
• Genetic variation inUGTgenes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry: Genetic Variants inUgtandCyp2c9, Nsaid Use and Colorectal Cancer Risk

  2014cites this paper
• Drug Response Heterogeneity and the Genetic Variability of Cytochrome P450–Metabolizing Enzymes

  2014cites this paper
• Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease

  2014cites this paper
• Use of physiologically based pharmacokinetic models coupled with pharmacodynamic models to assess the clinical relevance of current bioequivalence criteria for generic drug products containing Ibuprofen.

  2014cites this paper
• SVM Classification and CoMSIA Modeling of UGT1A6 Interacting Molecules

  2014cites this paper
• Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions

  2014cites this paper
• The utility of trout hepatic cells in the prediction of xenobiotic bioaccumulation and environmental persistence

  2013cites this paper
• Diclofenac removal in urine using strong-base anion exchange polymer resins.

  2013cites this paper
• Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs

  2013cites this paper